Treatment of elderly patients with chronic lymphocytic leukemia.
about
Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing OncologistTherapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemiaIdelalisib and rituximab in relapsed chronic lymphocytic leukemiaSuccessful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACTTreatment practice in the elderly patient with chronic lymphocytic leukemia-analysis of the combined SEER and Medicare database.Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL.Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia.Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance.Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic modelClinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia.Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach.Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid LeukemiaManagement of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach.A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia.Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015Practical approach to management of chronic lymphocytic leukemiaPresenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.Chronic lymphocytic leukemia in less fit patients: "slow-go".Treatment of older patients with chronic lymphocytic leukemia.The role of chemotherapy in managing chronic lymphocytic leukemia: optimizing combinations with targeted therapy.Treatment of elderly patients with chronic lymphocytic leukemia: an unmet cinical need.Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG).Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective review.First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.Targeted Therapy in Chronic Lymphocytic Leukemia (CLL).Individual differences in physical symptom burden and psychological responses in individuals with chronic lymphocytic leukemia.Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification.Impact of active surveillance, chlorambucil, and other therapy on health-related quality of life in patients with CLL/SLL in the Netherlands.Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma.Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells.
P2860
Q26775986-C7855142-E75F-4A75-B371-79324E860E5AQ28087378-6E2B61F5-42CE-4EB1-88A8-B66374535765Q28306347-0B10F7BD-9F50-43CF-BC7B-621516CB8606Q33394308-875B2E07-3E96-4B3E-AA3F-17A9EDAB0FF7Q33409149-FA546770-DBA1-4FDD-BC83-26C8EA8B8921Q33425372-699676CD-0109-4B15-AC3E-EC8B5CB15FB9Q33846793-FE83321E-2BF6-400C-902D-740AAC6BCA95Q34008866-88333A2E-D4B3-4F24-A825-EEA397309FE0Q34009041-278CAE60-2FA1-4E79-B5DB-D01E47B65C28Q34255124-E5A146CC-8F30-4866-861D-D930E33B9011Q34272532-84230D46-9A77-435E-9198-BE32B876E985Q35110582-E171F5D3-2FB6-4775-BC33-908B0819E38DQ35794457-BF6F94B1-31BA-49E7-8CD6-447816999C43Q36161529-61DF7B5A-8AAA-405B-8197-1C55A97F589AQ36251887-18C637DC-E622-4919-8777-FE51E3715587Q36519986-1667604B-6E43-49FD-A196-4689D5B0F83FQ36826893-B6365BAB-F449-4D7D-88E8-ED0EE9D29B3EQ36845277-9FDF69FE-906D-43BF-956B-71FD12A81D61Q37879960-1D2E7DD4-FD0A-41BE-99B0-0BE3831AE6DCQ37903038-A10DFC65-D290-4A45-806C-B082BF25153AQ37974861-DAEF07A1-C7EC-490B-9FF4-15455A0D020EQ38126946-77632234-1E24-4114-AC7E-C08CFA870227Q38132818-6BFAC269-DB9A-479D-ABFB-D37A19DF75D1Q38579008-ADEDB015-7A44-4FDE-A074-AC5D5583C53DQ38676408-C494BB61-C5EC-4FC2-ABD2-B87D6FAA4B47Q38791698-F064E37B-81A6-4EED-82BC-45BC42FDEB20Q38850667-F2EF0A43-FED1-4380-9B83-AB9C390EFD99Q38982682-200F01F3-D084-44EF-8AB7-A951C1949A18Q39475634-6BA50F25-54C6-48D5-B215-2DD5E936763BQ47094907-160DC7F8-6DA4-4541-96D4-B6FA0D59F8CBQ48070488-3C29E9E9-CE9F-4C05-B076-D32ECABFA0C6Q52646820-71E0DE4B-E172-4EF6-A289-647763811CF2Q53244764-F2AB25AD-1348-437C-9F7E-4614E426D0FEQ54407620-312B72C4-2F3C-433B-BC64-B06858126E88
P2860
Treatment of elderly patients with chronic lymphocytic leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of elderly patients with chronic lymphocytic leukemia.
@en
Treatment of elderly patients with chronic lymphocytic leukemia.
@nl
type
label
Treatment of elderly patients with chronic lymphocytic leukemia.
@en
Treatment of elderly patients with chronic lymphocytic leukemia.
@nl
prefLabel
Treatment of elderly patients with chronic lymphocytic leukemia.
@en
Treatment of elderly patients with chronic lymphocytic leukemia.
@nl
P2860
P50
P921
P1433
P1476
Treatment of elderly patients with chronic lymphocytic leukemia.
@en
P2093
Valentin Goede
P2860
P304
P356
10.1080/10428190802688517
P577
2009-02-01T00:00:00Z